Allianz Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Allianz Asset Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-214,270	Closed	-$38.5M	–	2826
2017 Q3	$38.5M	Buy	214,270 +156,001	+268%	+$21.7M	0.03%	618
2017 Q2	$6M	Buy	58,269 +6,391	+12%	+$522K	0.01%	1519
2017 Q1	$4.07M	Buy	51,878 +861	+2%	+$53.2K	﹤0.01%	1714
2016 Q4	$2.29M	Sell	51,017 -14,830	-23%	-$727K	﹤0.01%	1925
2016 Q3	$3.68M	Sell	65,847 -4,634	-7%	-$258K	﹤0.01%	1742
2016 Q2	$3.52M	Buy	+70,481	New	+$3.46M	﹤0.01%	1665
2015 Q2	–	Sell	-81,620	Closed	-$4.71M	–	2577
2015 Q1	$4.71M	Buy	81,620 +38,810	+91%	+$2.6M	0.01%	1233
2014 Q4	$2.47M	Buy	+42,810	New	+$1.8M	﹤0.01%	1460

Allianz Asset Management's KITE Position: Q4 2017 in Review

Allianz Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 214,270 shares — an estimated $38.5M sold.

Allianz Asset Management first reported a position in KITE in Q4 2014 and held it in 8 quarters. The position peaked at $38.5M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Allianz Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Allianz Asset Management sold 214,270 Kite Pharma, Inc. shares in Q4 2017, an estimated $38.5M.
Allianz Asset Management first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 8 quarters.
Allianz Asset Management's Kite Pharma, Inc. position peaked at $38.5M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Allianz Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.